San Diego, CA, United States of America

Burton Barnett

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dr. Falk Pharma Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Burton Barnett. Retrieved from https://idiyas.com/inventor/burton-barnett-ik4vze57

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Burton Barnett: Innovator in Antibody Development

Introduction

Burton Barnett is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for therapeutic applications, showcasing the importance of innovation in medical science.

Latest Patents

Burton Barnett holds a patent for "ANTI-CD30L ANTIBODIES AND USES THEREOF." This patent represents his innovative approach to targeting specific proteins for therapeutic purposes. With 1 patent to his name, Barnett's work exemplifies the intersection of science and technology in addressing health challenges.

Career Highlights

Barnett is currently employed at Dr. Falk Pharma GmbH, where he continues to advance his research in antibody development. His role at the company allows him to collaborate with other experts in the field, further enhancing the impact of his work.

Collaborations

Some of his notable coworkers include Mark Renshaw and Jessie-Farah Fecteau. Their collective expertise contributes to the innovative environment at Dr. Falk Pharma GmbH, fostering advancements in biotechnology.

Conclusion

Burton Barnett's contributions to the field of antibody development highlight the critical role of inventors in advancing medical science. His patent and ongoing work at Dr. Falk Pharma GmbH reflect a commitment to innovation that can lead to significant health improvements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…